Kepos Capital LP Nektar Therapeutics Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$31.58 - $46.35 $1.82 Million - $2.67 Million	-57,703 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$30.43 - $56.65 $1.56 Million - $2.9 Million	-51,236 Reduced 47.03%	57,703 $1.9 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $4.49 Million - $6.62 Million	96,591 Added 782.24%	108,939 $6.64 Million
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $708,775 - $1.34 Million	12,348 New	12,348 $1.31 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.